The principal market for our Common Stock is the New York Stock Exchange (NYSE). Our stock is also listed on the NYSE Euronext Brussels Exchange, the London Stock Exchange and the SIX Swiss Stock Exchange, as well as various United States regional stock exchanges.
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
Outside the U.S., Canada and
Puerto Rico: 1-781-575-4591
Please contact our Stock Transfer Agent and Registrar with inquiries concerning shareholder accounts of record and stock transfer matters, and also for information on the following services and programs:
Computershare Investment Program
Direct purchase of Pfizer stock
Automatic monthly investments
Book-entry share ownership
Direct deposit of dividends
Please refer to Pfizer's 2013 Form 10-K for a description of the substantial risks and uncertainties related to the forward-looking statements included in this Annual Review. Our Form 10-K is available on our website at www.pfizer.com/sec and on the Securities and Exchange Commission's website at www.sec.gov.
To review our most recent PAC and corporate political contributions report, go online at www.pfizer.com/pac.
Patients, customers and health care professionals who have questions about any of our products should call 1-800-438-1985.
Uninsured or underinsured patients who need help getting their Pfizer medicines should call Pfizer Helpful Answers, our family of patient assistance programs that provide Pfizer medicines for free or at a savings to patients who qualify. Some programs also offer reimbursement support services for insured patients. To learn more, visit www.PfizerHelpfulAnswers.com or call 1-866-706-2400.
You can find more information about Pfizer online at www.pfizer.com. Real-time news about Pfizer can be found on our Facebook page (www.facebook.com/Pfizer) and through Twitter (www.Twitter.com/Pfizer_news).
This Annual Review is produced by Pfizer's Corporate Affairs group.
Unless otherwise noted herein, the trademarks, logos and service marks appearing in the Annual Review, whether or not appearing with the trademark symbol, are owned or licensed by Pfizer Inc or its affiliates.
Design: Ideas On Purpose, New York